Sfoglia per AUTORE
ANTONUZZO A
Collezione AO Ordine Mauriziano
Items : 4
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial. in Frontiers in oncology / Front Oncol. 2022 Sep 15;12:925366. doi: 10.3389/fonc.2022.925366. eCollection 2022.
2022
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
Giordano M; Di Maio M; Numico G; Rossi M; Gunnellini M; Santini D; Zustovich F; Spinelli GP; Di Pede P; Mariani G; Corsi DC; Fabi A; Velutti L; Berruti A; Coletta D; Sammarco E; Galli L; Miccinesi G; Sbrana A; Roila F; Ripamonti CI; Antonuzzo A; Bossi P;
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders. in The oncologist / Oncologist. 2020 Jun;25(6):e946-e954. doi: 10.1634/theoncologist.2020-0035. Epub 2020 Mar 17.
2020
AO Ordine Mauriziano
AO Ordine Mauriziano
Antonuzzo A; Calabrò F; Quaglino P; Roila F; Sebastiani GD; Spina F; Pasqualetti G; Cortinovis D; Tagliaferri E; Peri A; Presotto EM; Egidi MF; Giacomelli L; Farroni F; Di Maio M; De Luca E; Danova M; Scottè F; Jordan K; Bossi P;
[Description of adverse events in publications of clinical trials: much room for improvement.]. in Recenti progressi in medicina / Recenti Prog Med. 2019 Jul-Aug;110(7):323-324. doi: 10.1701/3197.31742.
2019
AO Ordine Mauriziano
AO Ordine Mauriziano
Di Maio M; Antonuzzo A; Bossi P;
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Locati LD; Di Giannantonio V; Sbrana A; Musettini G; Sonetto C; Bironzo P; Botta L; Bossi P; Di Maio M; Antonuzzo A;